Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Eosinophilia“
Suchtreffer
Begriffe & Kennungen
Adtralza · 4.8 · Blood and lymphatic Common Eosinophilia system disorders Eye disorders Common Conjunctivitis allergic Uncommon
Eintrag öffnenAdtralza · 4.8 · Eosinophilia Adverse reactions of eosinophilia were reported in 1.3% of patients treated with tralokinumab and
Eintrag öffnenAmglidia · 4.8 · Blood affections have been observed, generally reversible when treatment stops. Hypereosinophilia, leucopenia,
Eintrag öffnenAngiolymphoide Hyperplasie mit Eosinophilie
Eintrag öffnenArava · 4.8 · 11 Rare: pancytopenia (probably by antiproliferative mechanism), leucopenia (leucocytes <2 G/L), eosinophilia
Eintrag öffnenArzneimittelinduziertes Hypersensitivitätssyndrom
Eintrag öffnenArzneimittelreaktion mit Eosinophilie und systemischen Symptomen
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.8 · Stevens-Johnson syndrome (SJS), erythema multiforme, toxic skin eruptions and drug rash with eosinophilia and
Eintrag öffnenCholib · 4.8 · 14 vasculitis, thrombocytopenia, eosinophilia, erythrocyte sedimentation rate (ESR) increased, arthritis and a
Eintrag öffnenClopidogrel HCS · 4.8 · 9 System Organ Common Uncommon Rare Very rare, not Class known* eosinophilia and systemic symptoms (DRESS), ra
Eintrag öffnenColonic eosinophilia
Eintrag öffnenCorlentor · 4.8 · System Organ Class Frequency Preferred Term Blood and lymphatic system Uncommon Eosinophilia disorders Metabol
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.8 · Rare drug reaction with eosinophilia and systemic symptoms*, Stevens-Johnson syndrome*
Eintrag öffnenDupixent · 4.8 · Eosinophilia Dupilumab-treated patients had a greater mean initial increase from baseline in eosinophil count
Eintrag öffnenDupixent · 4.8 · Eosinophilia Dupilumab-treated patients had a greater mean initial increase from baseline in eosinophil count
Eintrag öffnenDupixent · 4.8 · In children 6 to 11 years of age with moderate-to-severe asthma, eosinophilia (blood eosinophils ≥ 3,000 cells
Eintrag öffnenDupixent · 4.8 · In children 6 to 11 years of age with moderate-to-severe asthma, eosinophilia (blood eosinophils ≥ 3,000 cells
Eintrag öffnenDupixent · 4.8 · Treatment-emergent eosinophilia (≥ 5,000 cells/mcL) was observed in < 3 % of dupilumab-treated patients and <
Eintrag öffnenDupixent · 4.8 · Treatment-emergent eosinophilia (≥ 5,000 cells/mcL) was observed in < 3 % of dupilumab-treated patients and <
Eintrag öffnenDupixent · 4.8 · Treatment-emergent eosinophilia (≥5,000 cells/mcL) was observed in 8.4% of dupilumab-treated patients and 0% i
Eintrag öffnen